3D structures of HPK1: Difference between revisions
Michal Harel (talk | contribs) New page: ==3D structures of mitogen-activated protein kinase kinase kinase kinase 1 or HPK1 or hematopoietic progenitor kinase== Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVIS... |
Michal Harel (talk | contribs) No edit summary |
||
| Line 8: | Line 8: | ||
[[6ng0]] – hHPK1 kinase domain (mutant) + cancer drug<br /> | [[6ng0]] – hHPK1 kinase domain (mutant) + cancer drug<br /> | ||
[[6cqf]], [[7l24]]. [[7l25]], [[7l26]], [[7m0k]], [[7m0m]], [[7r9l]], [[7r9n]], [[7r9p]], [[7r9t]], [[7siu]], [[8cdw]], [[8cij]] – hHPK1 kinase domain + inhibitor <br /> | [[6cqf]], [[7l24]]. [[7l25]], [[7l26]], [[7m0k]], [[7m0m]], [[7r9l]], [[7r9n]], [[7r9p]], [[7r9t]], [[7siu]], [[8cdw]], [[8cij]] – hHPK1 kinase domain + inhibitor <br /> | ||
[ | [[6cqd]] – hHPK1 kinase domain + AMPPNP<br /> | ||
[[6cqe]], [[7kac]], [[8fh4]], [[8fjz]], [[8fko]], [[8xn7]] – hHPK1 kinase domain (mutant) + inhibitor <br /> | [[6cqe]], [[7kac]], [[8fh4]], [[8fjz]], [[8fko]], [[8xn7]] – hHPK1 kinase domain (mutant) + inhibitor <br /> | ||
[[6nfz]] – hHPK1 kinase domain (di-P) + cancer drug<br /> | [[6nfz]] – hHPK1 kinase domain (di-P) + cancer drug<br /> | ||